These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 22351933)
1. Agammaglobulinemia and absent B lineage cells in a patient lacking the p85α subunit of PI3K. Conley ME; Dobbs AK; Quintana AM; Bosompem A; Wang YD; Coustan-Smith E; Smith AM; Perez EE; Murray PJ J Exp Med; 2012 Mar; 209(3):463-70. PubMed ID: 22351933 [TBL] [Abstract][Full Text] [Related]
2. Divergent roles of the regulatory subunits of class IA PI3K. Kim CW; Lee JM; Park SW Front Endocrinol (Lausanne); 2023; 14():1152579. PubMed ID: 38317714 [TBL] [Abstract][Full Text] [Related]
3. Reduced T cell expansion by a superantigen as a result of impaired B cell development in mice deficient for the p85alpha regulatory subunit of PI3K. Arimura Y; Ezaki T; Koyanagi M; Uchiyama T; Koyasu S; Yagi J J Leukoc Biol; 2010 Mar; 87(3):493-500. PubMed ID: 20007249 [TBL] [Abstract][Full Text] [Related]
4. Mutation analysis of the Bruton's tyrosine kinase gene in X-linked agammaglobulinemia: identification of a mutation which affects the same codon as is altered in immunodeficient xid mice. de Weers M; Mensink RG; Kraakman ME; Schuurman RK; Hendriks RW Hum Mol Genet; 1994 Jan; 3(1):161-6. PubMed ID: 8162018 [TBL] [Abstract][Full Text] [Related]
5. Class I(A) PI3Kinase regulatory subunit, p85α, mediates mast cell development through regulation of growth and survival related genes. Krishnan S; Mali RS; Koehler KR; Vemula S; Chatterjee A; Ghosh J; Ramdas B; Ma P; Hashino E; Kapur R PLoS One; 2012; 7(1):e28979. PubMed ID: 22238586 [TBL] [Abstract][Full Text] [Related]
6. Genetic disruption of the PI3K regulatory subunits, p85α, p55α, and p50α, normalizes mutant PTPN11-induced hypersensitivity to GM-CSF. Goodwin CB; Yang Z; Yin F; Yu M; Chan RJ Haematologica; 2012 Jul; 97(7):1042-7. PubMed ID: 22315502 [TBL] [Abstract][Full Text] [Related]
7. Heterozygous splice mutation in PIK3R1 causes human immunodeficiency with lymphoproliferation due to dominant activation of PI3K. Lucas CL; Zhang Y; Venida A; Wang Y; Hughes J; McElwee J; Butrick M; Matthews H; Price S; Biancalana M; Wang X; Richards M; Pozos T; Barlan I; Ozen A; Rao VK; Su HC; Lenardo MJ J Exp Med; 2014 Dec; 211(13):2537-47. PubMed ID: 25488983 [TBL] [Abstract][Full Text] [Related]
8. Cutting edge: lack of peripheral B cells and severe agammaglobulinemia in mice simultaneously lacking Bruton's tyrosine kinase and the B cell-specific transcriptional coactivator OBF-1. Schubart DB; Rolink A; Schubart K; Matthias P J Immunol; 2000 Jan; 164(1):18-22. PubMed ID: 10604987 [TBL] [Abstract][Full Text] [Related]
9. Absent B cells, agammaglobulinemia, and hypertrophic cardiomyopathy in folliculin-interacting protein 1 deficiency. Saettini F; Poli C; Vengoechea J; Bonanomi S; Orellana JC; Fazio G; Rodriguez FH; Noguera LP; Booth C; Jarur-Chamy V; Shams M; Iascone M; Vukic M; Gasperini S; Quadri M; Barroeta Seijas A; Rivers E; Mauri M; Badolato R; Cazzaniga G; Bugarin C; Gaipa G; Kroes WGM; Moratto D; van Oostaijen-Ten Dam MM; Baas F; van der Maarel S; Piazza R; Coban-Akdemir ZH; Lupski JR; Yuan B; Chinn IK; Daxinger L; Biondi A Blood; 2021 Jan; 137(4):493-499. PubMed ID: 32905580 [TBL] [Abstract][Full Text] [Related]
10. SHORT syndrome with partial lipodystrophy due to impaired phosphatidylinositol 3 kinase signaling. Chudasama KK; Winnay J; Johansson S; Claudi T; König R; Haldorsen I; Johansson B; Woo JR; Aarskog D; Sagen JV; Kahn CR; Molven A; Njølstad PR Am J Hum Genet; 2013 Jul; 93(1):150-7. PubMed ID: 23810379 [TBL] [Abstract][Full Text] [Related]
11. B-cells absence in patients diagnosed as inborn errors of immunity: a registry-based study. Khoshnevisan R; Hassanzadeh S; Klein C; Rohlfs M; Grimbacher B; Molavi N; Zamanifar A; Khoshnevisan A; Jafari M; Bagherpour B; Behnam M; Najafi S; Sherkat R Immunogenetics; 2024 Jun; 76(3):189-202. PubMed ID: 38683392 [TBL] [Abstract][Full Text] [Related]
12. A recurrent dominant negative E47 mutation causes agammaglobulinemia and BCR(-) B cells. Boisson B; Wang YD; Bosompem A; Ma CS; Lim A; Kochetkov T; Tangye SG; Casanova JL; Conley ME J Clin Invest; 2013 Nov; 123(11):4781-5. PubMed ID: 24216514 [TBL] [Abstract][Full Text] [Related]
13. A human non-XLA immunodeficiency disease characterized by blockage of B cell development at an early proB cell stage. Meffre E; LeDeist F; de Saint-Basile G; Deville A; Fougereau M; Fischer A; Schiff C J Clin Invest; 1996 Oct; 98(7):1519-26. PubMed ID: 8833898 [TBL] [Abstract][Full Text] [Related]
14. Role of phosphoinositide 3-kinase regulatory isoforms in development and actin rearrangement. Brachmann SM; Yballe CM; Innocenti M; Deane JA; Fruman DA; Thomas SM; Cantley LC Mol Cell Biol; 2005 Apr; 25(7):2593-606. PubMed ID: 15767666 [TBL] [Abstract][Full Text] [Related]
15. Altered signaling and cell cycle regulation in embryonal stem cells with a disruption of the gene for phosphoinositide 3-kinase regulatory subunit p85alpha. Hallmann D; Trümper K; Trusheim H; Ueki K; Kahn CR; Cantley LC; Fruman DA; Hörsch D J Biol Chem; 2003 Feb; 278(7):5099-108. PubMed ID: 12435753 [TBL] [Abstract][Full Text] [Related]
16. Posttranscriptional regulation of the p85α adapter subunit of phosphatidylinositol 3-kinase in human leukemia cells. Hofmann BT; Hoxha E; Mohr E; Schulz K; Jücker M Leuk Lymphoma; 2011 Mar; 52(3):467-77. PubMed ID: 21077741 [TBL] [Abstract][Full Text] [Related]
17. Novel Igalpha (CD79a) gene mutation in a Turkish patient with B cell-deficient agammaglobulinemia. Wang Y; Kanegane H; Sanal O; Tezcan I; Ersoy F; Futatani T; Miyawaki T Am J Med Genet; 2002 Apr; 108(4):333-6. PubMed ID: 11920841 [TBL] [Abstract][Full Text] [Related]
18. Role of p85α in neutrophil extra- and intracellular reactive oxygen species generation. Li XJ; Deng L; Brandt SL; Goodwin CB; Ma P; Yang Z; Mali RS; Liu Z; Kapur R; Serezani CH; Chan RJ Oncotarget; 2016 Apr; 7(17):23096-105. PubMed ID: 27049833 [TBL] [Abstract][Full Text] [Related]
19. A non-XLA primary deficiency causes the earliest known defect of B cell differentiation in humans: a comparison with an XLA case. Meffre E; LeDeist F; de Saint-Basile G; Deville A; Fougereau M; Fischer A; Schiff C Immunol Lett; 1997 Jun; 57(1-3):93-9. PubMed ID: 9232432 [TBL] [Abstract][Full Text] [Related]
20. Variant PIK3R1 Hypermorphic Mutation and Clinical Phenotypes in a Family with Short Statures, Mild Immunodeficiency and Lymphoma. Hauck F; Magg T; Krolo A; Bilic I; Hirschmugl T; Laass M; Rösen-Wolff A; Luksch H; Boztug K; Roesler J Klin Padiatr; 2017 May; 229(3):113-117. PubMed ID: 28561224 [No Abstract] [Full Text] [Related] [Next] [New Search]